Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3487385011 | Product containing metformin and sitagliptin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3715707019 | Metformin- and sitagliptin-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4537851000052111 | läkemedel som innehåller metformin och sitagliptin | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing metformin and sitagliptin (medicinal product) | Is a | Product containing sitagliptin (medicinal product) | true | Inferred relationship | Some | ||
| Product containing metformin and sitagliptin (medicinal product) | Is a | Product containing metformin (medicinal product) | true | Inferred relationship | Some | ||
| Product containing metformin and sitagliptin (medicinal product) | Has active ingredient | Metformin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing metformin and sitagliptin (medicinal product) | Has active ingredient | Sitagliptin phosphate (substance) | false | Inferred relationship | Some | ||
| Product containing metformin and sitagliptin (medicinal product) | Is a | oralt blodsockersänkande kombinationspreparat | false | Inferred relationship | Some | ||
| Product containing metformin and sitagliptin (medicinal product) | Has active ingredient | Sitagliptin (substance) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Product containing metformin and sitagliptin (medicinal product) | Inferred relationship | Some | |
| Metformin hydrochloride 500 mg and sitagliptin phosphate 50 mg oral tablet | Is a | False | Product containing metformin and sitagliptin (medicinal product) | Inferred relationship | Some | |
| Product containing metformin and sitagliptin in oral dose form (medicinal product form) | Is a | True | Product containing metformin and sitagliptin (medicinal product) | Inferred relationship | Some | |
| Product containing only metformin and sitagliptin (medicinal product) | Is a | True | Product containing metformin and sitagliptin (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR